Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

Metis TechBio-P Shares Surge Over 10% as AI Drug Discovery Sector Enters Validation Phase

Stock News
·
Jun 29

Huiyu Pharmaceutical Subsidiary Secures International Market Approvals for Multiple Products

Stock News
·
Jun 25

ASCLETIS PHARMA CONDUCTS HK$2.02 MILLION SHARE BUYBACK

Stock News
·
Jun 24

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

Stock News
·
Jun 23

ASCLETIS-B Executes Share Buyback on June 22, Spending HK$1.901 Million

Stock News
·
Jun 22

Jianyou Shares' Board Secretary Huang Xiwei: Global Strategy Anchored, Three-Phase Plan Strengthens Full Pharmaceutical Industry Chain

Deep News
·
Jun 22

Hong Kong IPO Prospectus for Zelgen Biopharmaceutical Lapses

Stock News
·
Jun 22

Targeting the Brain's 'Wake Switch': Alkermes's Narcolepsy Drug Shows Promising Mid-Stage Data, Igniting Race in Orexin Pathway

Stock News
·
Jun 18

HighLight Pharma's Second Hong Kong Listing Bid: Zero Revenue, Pipeline Gaps, and Core Product's Commercial Viability Questioned Under $1.2 Billion Bet Pressure

Deep News
·
Jun 18

ASCLETIS-B Executes Share Buyback Totaling HK$1.97 Million

Stock News
·
Jun 17

Legal Claims Initiated Against Shenwu Energy Saving, Hainan Poly Pharm. Case Resubmitted to Court

Deep News
·
Jun 17

Legal Action Against Puli Pharmaceutical Continues to Gather Momentum, Initial Court Victory Secured

Deep News
·
Jun 17

ASCLETIS-B Executes Share Buyback, Spending HK$1.86 Million

Stock News
·
Jun 16

ASCLETIS-B Executes Share Buyback, Spending HK$1,918,300 on June 15

Stock News
·
Jun 15

ASCLETIS-B Executes HK$1.97 Million Share Buyback on June 11

Stock News
·
Jun 11

ASCLETIS-B Executes Share Buyback, Spending Nearly HK$2 Million

Stock News
·
Jun 10

Biopharmaceutical Firm Reapplies for Hong Kong Listing Amid Ongoing Financial Losses

Stock News
·
Jun 09

Ocumension Sets 30 Jun 2026 AGM; Seeks 20% Issuance Mandate, 10% Buy-back Limit and 8% Option Pool Refresh

Bulletin Express
·
Jun 08

ASCLETIS-B Executes Share Buyback, Spending HK$2 Million on June 8

Stock News
·
Jun 08

PegBio Co-B Shares Surge Over 6% Following Receipt of HKD 61 Million Initial Royalty Payment for Commercialization of Drug Candidate

Stock News
·
Jun 08